InsidersTradesSigma
Explore the complete record of transactions filed by 남기연, 董事长兼首席执行官. Officer active across 2 companies, notably 큐리언트. Aggregated, 1 filings have been published. History available since 25 March 2026. The latest transaction was filed on 25 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Nam Ki-yeon is the Chairman & CEO of Curient, an innovative company in the biotechnology sector. Under his leadership, Curient focuses on developing advanced therapeutic solutions. His expertise in management and product development is crucial to the company's mission of transforming healthcare.